Guardian Pharmacy Services, Inc.
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.23B | 1.17B | 1.12B | 1.08B | 1.05B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.23B | 1.17B | 1.12B | 1.08B | 1.05B |
| Cost of Revenue | 984.04M | 939.06M | 896.10M | 869.68M | 837.88M |
| Gross Profit | 244.37M | 231.85M | 223.16M | 215.29M | 208.31M |
| SG&A Expenses | 302.85M | 272.54M | 165.58M | 144.88M | 143.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.29B | 1.21B | 1.06B | 1.01B | 981.80M |
| Operating Income | -58.48M | -40.70M | 57.58M | 70.41M | 64.40M |
| Income Before Tax | -66.48M | -68.14M | 30.51M | 43.48M | 37.72M |
| Income Tax Expenses | 4.56M | 176.00K | 0.00 | -- | -- |
| Earnings from Continuing Operations | -71.03 | -68.32 | 30.51 | 43.48 | 37.72 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -16.25M | -18.90M | -16.37M | -14.57M | -13.82M |
| Net Income | -87.29M | -87.21M | 14.14M | 28.90M | 23.90M |
| EBIT | -58.48M | -40.70M | 57.58M | 70.41M | 64.40M |
| EBITDA | -38.71M | -21.37M | 76.56M | 89.00M | 82.63M |
| EPS Basic | -1.91 | -2.10 | -0.11 | -- | -- |
| Normalized Basic EPS | -0.94 | -1.15 | 0.04 | -- | -- |
| EPS Diluted | -1.92 | -2.11 | -0.11 | -- | -- |
| Normalized Diluted EPS | -0.94 | -1.15 | 0.04 | -- | -- |
| Average Basic Shares Outstanding | 184.33M | 122.29M | 61.14M | -- | -- |
| Average Diluted Shares Outstanding | 185.01M | 122.29M | 61.14M | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -41.30% | -52.80% | 284.86% | 152.67% | 160.75% |